Tallac Therapeutics
Burlingame
About Tallac Therapeutics
Tallac Therapeutics offers next-generation immunotherapies for cancer patients. The company is based in Burlingame, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $88.2M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Aug 2023)
- Website: tallactherapeutics.com
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/tallac-therapeutics-2574 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.